Pakistan is an endemic area for malaria. Malaria is considered to be associated with thrombocytopenia. The frequency of thrombocytopenia varies in different studies. This study was done to determine the frequency of thrombocytopenia among patients with malaria. Objectives: To determine the frequency and severity of thrombocytopenia in patients of malaria. Study Design: Cross-sectional survey. Setting: Pathology Department, Nishtar Medical University, Multan. Period: Eight months; (04-03-2018 to 03-11-2018). Materials & Methods: One hundred and fifty patients with malaria were included in the study. Platelet count of all the patients was done on Sysmex KX-21. The patients were categorized according to the presence of thrombocytopenia (yes or no) and the severity of thrombocytopenia (mild, moderate or severe). The data was described as frequency distribution table. Results: The mean age of the patients was 31.81 + 15.31 years. There were 46 (30.7%) female patients and 104 (69.3%) male patients. Thrombocytopenia was present among 103 (68.7%) patients. Mild, moderate and severe thrombocytopenia was found in 60 (58.3%), 24 (23.3%) and 19 (18.4%) patients, respectively. Conclusion:
INTRODUCTION
Malaria is a vector born disease caused by the bite of the female Anopheles mosquito inoculating the sporozoites in the human blood stream leading to clinical manifestations. 1 Malaria affects approximately 5% of the world population, being endemic in 103 countries and causes 1-3 million deaths each year. About 270 million people are infected each year. 2 WHO forecasts a 16% growth in annual cases of malaria. 3, 4 In Pakistan, half a million malaria cases occur annually and mortality rate is as high as 50 thousand deaths per year, mostly affecting infants, children and pregnant ladies. 5 Malaria can be caused by any of four parasites of plasmodium species namely Plasmodium Vivax, Plasmodium Falciparum, Plasmodium ovale, and Plasmodium malariae, out of which Plasmodium Falciparum is the main species responsible for the most of these deaths. 6 Early diagnosis remains the key for the effective management of malaria for a favorable outcome. 7 Clinically malaria mimics many diseases and there are no absolute diagnostic clinical features. Unfortunately, most of the diagnostic facilities are not available in all areas endemic for malaria. In such settings changes in hematological parameters can be of great help to support the diagnosis. The presence of thrombocytopenia in a patient living in endemic area has become a highly sensitive diagnostic marker with 60% sensitivity and 88% specificity for the diagnosis of malaria. The speculated mechanisms leading to thrombocytopenia in malaria are: hypersplenism, bone marrow depressions, coagulation disturbances, antibody mediated platelet destruction, oxidative stress, and the role of platelets as cofactors in triggering severe malaria. 8 Thrombocytopenia is one of the most common complications of both Plasmodium vivax and Plasmodium falciparum malaria 9 , defined as platelet count less than 150 × 10 9 /L. It is divided into three main categories; mild (100 to 150x10 9 /L), moderate (50 to 99x10 9 /L), and severe (< 50x10 9 /L). 10 Frequency of thrombocytopenia in malaria is found to be 70%. Mild thrombocytopenia is observed in 70% cases, moderate in 22% and severe in 8% cases. 11 Thrombocytopenic malaria, in contrast to the non-thrombocytopenic 12 variety, correlates with a higher degree of parasitemia and increased cytokine production. 13 Bleeding in thrombocytopenia is however not common, and occurs in less than 5-10% of cases of severe malaria. 14, 15 Thrombocytopenia is considered to be an important predictor of severity of childhood Falciparum malaria. 16 In developing countries where malaria is endemic, no such study has been conducted before with special emphasis on thrombocytopenia and its degree of severity. Determination of frequency of thrombocytopenia in malaria endemic area will help in establishing malaria as an important cause of thrombocytopenia and will help clinicians in early diagnosis of these malaria patients. This study will also help in determining degree of severity of thrombocytopenia associated with malaria. This will assist in formulating guidelines and management plan for treatment of this grave complication of malaria according to its degree of severity.
OBJECTIVES
The objectives of this study were: 1. To determine the frequency of thrombocytopenia in patients of malaria. 2. To determine the severity of thrombocytopenia in patients of malaria.
MATERIAL AND METHODS
After approval of study by ethical board of the institution. A total of 150 patients of both genders ranging from 12-80 years with a history of fever less than seven days duration with no localizing signs and presence of malarial parasite in the peripheral blood film presenting to Pathology laboratory of Nishtar Medical University, Multan over a period of 8 months duration, from 04/03/2018 to 03/11/2018, were included in the study. Patients with malarial parasite in peripheral blood smear but with other causes of thrombocytopenia e.g.; marrow failure, marrow infiltration, ITP, chronic liver disease, bleeding disorders, drug intake such as septran, thiazides and chemotherapeutic agents assessed through history, bone marrow examination were excluded from the study, because in these conditions cause of thrombocytopenia was not clear.
After explaining patients about pros and cons of the procedure and taking informed consent and ensuring their confidentiality, three milliliter venous blood was collected in EDTA vacutainers, from each patient. Thick and thin blood smears were prepared from each specimen, stained with Giemsa stain and examined for malarial parasite under light microscope using100× oil immersion lens. Complete blood counts of each specimen of all malaria cases were performed by Sysmex KX-21 automated hematology analyzer and platelet count of all cases were noted. Platelet counts of malaria patients having thrombocytopenia were also re-assessed on Giemsa stained blood smear by light microscope using 100× oil immersion lens in Pathology department of Nishtar Medical University, Multan.
Effect modifiers were Plasmodium species and were dealt by stratification. Data was analyzed on SPSS version 20. Quantitative variables like patient's age were analyzed by mean ± standard deviation. Qualitative variables including the 3 gender and the presence of thrombocytopenia and its severity were presented in the form of frequencies and percentages. Chi square test was used to analyze the difference between two groups and P value equal or less than 0.05 was considered as significant. ( Figure-1) The mean thrombocyte count in study population was 125.98 + 63.916.56 X 10 9 / L (range 3 -320 X 10 9 / L). Among the 150 patients included in the study, thrombocytopenia was present among 103 (68.7%) patients, while 47 (31.3%) patients had normal platelet count. (Figure-2) Out of 103 patients who had thrombocytopenia, 93 patients were infected with P. vivax and 10 infected with P. Falciparum (Table-I 
RESULTS
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DISCUSSION
In this study, we included 150 patients of malaria to determine the frequency and severity of thrombocytopenia. This was a prospective crosssectional survey which was conducted in a wellequipped tertiary care unit. 17 , documented a small difference in male and female population suffering from malaria, although male population was dominated. In their study, they found that 58.5% patients were males and 41.5% were females. The trend in literature reflects that malaria is seen more frequently among male as compared to female population possibly because females in this area have less access to medical facilities to get diagnosed due to poverty, socio economic issues and ignorance. The mean platelet count in our study was 125.98 + 63.91 x 10 9 / L. This was very close to that of study by Jadhav et al, which showed that mean platelet count was 1,15x 10 9 /L (±SD 64,580) with a range of 8000-5,73x10 9 /L. The mean platelet count in study by Ansari S, et al was 12x10±450 x10 9 /L. Our patients suffering from plasmodium vivax did not show a very low mean platelet count. This may be due to the reason that Plasmodium falciparum is notorious for causing a more drop in platelet count as compared to vivax and the frequency of Plasmodium falciparum in our study was very low. The mean platelet count in patients affected with P falciparum was 100,900/ µl (±SD 75,437). So, there is a more drop in platelet count in patients with P falciparum group.
In our study, 68.7% patients suffered from thrombocytopenia. This is in accordance with other studies. In a study by Zaid In our study, we observed that Plasmodium Falciparum is associated with a more drop in platelet count as compared to Plasmodium Vivax (P value=0.032). It is very close to study by Jadhav UM, et al, who also noted significant association between severity of thrombocytopenia and type of malaria.
This study had some limitations. This was single center study with small sample size. This study was conducted in a tertiary care hospital where most of the patients come to the hospital with serious or complicated problems rather for fever or malaria. Due to poverty and ignorance in our population, most of the time, the problems remain undiagnosed or maltreated. So, the frequency of thrombocytopenia may be higher than observed in our study.
CONCLUSION
This study concludes that frequency of thrombocytopenia is very high among patients with malaria. Severity of thrombocytopenia is mild to moderate, with few patients presenting with severe thrombocytopenia. This finding signifies that malaria is an important cause of thrombocytopenia. So, the platelet count should be monitored closely in patients of malaria to avoid possible complications of thrombocytopenia. Copyright©18 Feb, 2019.
